Risk factors and prognosis of interstitial lung disease for primary Sjogren syndrome patients: A retrospective case-control study

被引:2
|
作者
Huang, Yichen [1 ]
Qiu, Yanran [1 ]
Xie, Zhijun [2 ]
Zhang, Fengqi [2 ]
Zhang, Yi [2 ]
Guan, Meihui [1 ]
Wang, Xinchang [1 ]
Cai, Wanru [1 ]
Sun, Jing [1 ]
机构
[1] Zhejiang Chinese Med Univ, Clin Coll 2, Hangzhou, Zhejiang, Peoples R China
[2] Zhejiang Chinese Med Univ, Sch Basic Med Sci, Hangzhou, Zhejiang, Peoples R China
关键词
Case-control study; Interstitial lung disease; Primary Sjogren syndrome; Risk factor; MORTALITY; CLASSIFICATION; UPDATE;
D O I
10.1007/s10067-023-06596-7
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective To determine the prevalence, clinical features, risk factors, and prognosis of interstitial lung disease (ILD) in patients with primary Sjogren's syndrome (pSS).Methods Data from 274 pSS patients from August 2013 to August 2022 were reviewed. The clinical features of pSS with ILD were revealed. Logistic regression was used to determine risk factors for ILD in pSS patients. Survival analysis and Cox regression were used to analyse the prognosis and prognostic factors of pSS patients.Results In pSS patients, the prevalence of ILD was 22.3% (61/274). The pSS patients with ILD were characterized by a late onset and long disease course, with a nonspecific interstitial pneumonia (NSIP) pattern as the predominant high-resolution computed tomography (HRCT) finding. Logistic regression results indicated that an age over 50 years old (OR 4.786, 95% CI 1.602-14.299; P = 0.005), purpuric rash (OR 4.695, 95% CI 1.537-14.339; P = 0.007), AMA-M2 antibody positivity (OR 2.582, 95% CI 1.166-5.722; P = 0.019), and diabetes (OR 2.514, 95% CI 1.025-6.167; P = 0.044) were risk factors for ILD in pSS patients. Cox regression results showed that advanced age (HR 1.240, 95% CI 1.088-1.413; P = 0.001) and cancer history (HR 8.411, 95% CI 1.771-39.934; P = 0.007) were risk factors for pSS patient survival.Conclusion This study showed that pSS patients with ILD tended to have a late onset and long course of pSS. An age over 50 years, purpuric rash, AMA-M2 antibody positivity, and diabetes were risk factors for ILD in pSS patients. Advanced age and cancer history were prognostic factors in pSS patients.
引用
收藏
页码:3033 / 3041
页数:9
相关论文
共 50 条
  • [31] Anti-Ro52 antibodies are a risk factor for interstitial lung disease in primary Sjogren syndrome
    Buvry, Charlotte
    Cassagnes, Lucie
    Tekath, Marielle
    Artigues, Maxime
    Pereira, Bruno
    Rieu, Virginie
    Le Guenno, Guillaume
    Tournadre, Anne
    Ruivard, Marc
    Grobost, Vincent
    RESPIRATORY MEDICINE, 2020, 163
  • [32] Acute Exacerbation of Interstitial Lung Disease in Adult Patients With Idiopathic Inflammatory Myopathies: A Retrospective Case-Control Study
    Liang, Junyu
    Cao, Heng
    Ke, Yini
    Sun, Chuanyin
    Chen, Weiqian
    Lin, Jin
    FRONTIERS IN MEDICINE, 2020, 7
  • [33] Serum Metabolomic Profiling in Rheumatoid Arthritis Patients With Interstitial Lung Disease: A Case-Control Study
    Furukawa, Hiroshi
    Oka, Shomi
    Shimada, Kota
    Okamoto, Akira
    Hashimoto, Atsushi
    Komiya, Akiko
    Saisho, Koichiro
    Yoshikawa, Norie
    Katayama, Masao
    Matsui, Toshihiro
    Fukui, Naoshi
    Migita, Kiyoshi
    Tohma, Shigeto
    FRONTIERS IN MEDICINE, 2020, 7
  • [34] Hemorheological profile in primary Sjogren's syndrome: A case-control study
    Vaya, Amparo
    Suescun, Marta
    Mico, Luisa
    Todoli, Jose
    Ricart, Jose M.
    CLINICAL HEMORHEOLOGY AND MICROCIRCULATION, 2011, 47 (04) : 287 - 293
  • [35] Association of disease activity with acute exacerbation of interstitial lung disease during tocilizumab treatment in patients with rheumatoid arthritis: a retrospective, case-control study
    Akiyama, Mitsuhiro
    Kaneko, Yuko
    Yamaoka, Kunihiro
    Kondo, Harumi
    Takeuchi, Tsutomu
    RHEUMATOLOGY INTERNATIONAL, 2016, 36 (06) : 881 - 889
  • [36] Interstitial lung disease in Japanese patients with lung cancer - A cohort and nested case-control study
    Kudoh, Shoji
    Kato, Harubumi
    Nishiwaki, Yutaka
    Fukuoka, Masahiro
    Nakata, Kouichiro
    Ichinose, Yukito
    Tsuboi, Masahiro
    Yokota, Soichiro
    Nakagawa, Kazuhiko
    Suga, Moritaka
    Jiang, Haiyi
    Itoh, Yohji
    Armour, Alison
    Watkins, Claire
    Higenbottam, Tim
    Nyberg, Fredrik
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2008, 177 (12) : 1348 - 1357
  • [37] Comorbidities in Patients with Primary Sjogren's Syndrome: A Registry-based Case-control Study
    Kang, Jiunn-Horng
    Lin, Herng-Ching
    JOURNAL OF RHEUMATOLOGY, 2010, 37 (06) : 1188 - 1194
  • [38] Retrospective study of the clinical characteristics and risk factors of rheumatoid arthritis-associated interstitial lung disease
    Zhang, Yongfeng
    Li, Hongbin
    Wu, Nawei
    Dong, Xin
    Zheng, Yi
    CLINICAL RHEUMATOLOGY, 2017, 36 (04) : 817 - 823
  • [39] Laboratory risk factors for coexistent primary biliary cholangitis in patients with Sjogren's syndrome: a retrospective study
    Gao, Xuan
    Xiao, Guangzhi
    Yang, Fengfan
    Dou, Rongrong
    Xue, Miao
    Zhang, Yingying
    Zheng, Zhaohui
    Ding, Jin
    BMC GASTROENTEROLOGY, 2023, 23 (01)
  • [40] Biomarkers of interstitial lung disease associated with primary Sjogren's syndrome
    Weng, Lin
    Chen, Yaqiong
    Liang, Tao
    Lin, Yihua
    Liu, Dehao
    Yu, Ciyong
    Hu, Yudi
    Lui, Wei
    Liu, Yongliang
    Chen, Xiangfang
    Li, Qiyuan
    Ge, Shengxiang
    Ascherman, Dana P.
    Chen, Juan
    EUROPEAN JOURNAL OF MEDICAL RESEARCH, 2022, 27 (01)